About Orchestra Biomed Holdings, Inc. 
Orchestra Biomed Holdings, Inc.
Pharmaceuticals & Biotechnology
Health Sciences Acquisitions Corporation 2 is a blank check company. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. It intends to target companies domiciled in North America or Europe that are developing assets in the biopharma and medical technology sectors. It has generated no revenues.
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 16 Schemes (7.65%)
Foreign Institutions
Held by 22 Foreign Institutions (0.75%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
1 Million
(Quarterly Results - Sep 2025)
Net Profit:
-21 Million
Pharmaceuticals & Biotechnology
USD 221 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-1.48
-171.70%
5.05






